Literature DB >> 14608100

Dual regulation of cell proliferation and survival via activation of glucagon-like peptide-2 receptor signaling.

Jennifer L Estall1, Daniel J Drucker.   

Abstract

Peptide hormones regulate cell viability and tissue integrity, directly or indirectly, through activation of G-protein-coupled receptors via diverse mechanisms including stimulation of cell proliferation and inhibition of cell death. Glucagon-like peptide-2 (GLP-2) is a 33 amino acid peptide hormone released from intestinal endocrine cells following nutrient ingestion. GLP-2 stimulates intestinal crypt cell proliferation leading to expansion of the gastrointestinal mucosal epithelium. Exogenous GLP-2 administration attenuates intestinal injury in experimental models of gastrointestinal disease and improves intestinal absorption and nutritional status in human patients with intestinal failure secondary to short bowel syndrome. GLP-2 also promotes mucosal integrity via reduction of injury-associated apoptosis in the intestinal mucosa and directly reduces apoptosis in cells expressing the GLP-2 receptor in vitro. Hence, the regenerative and cytoprotective properties of GLP-2 contribute to its therapeutic potential for the treatment of patients with intestinal disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14608100     DOI: 10.1093/jn/133.11.3708

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  6 in total

1.  Cecal infusion of butyrate increases intestinal cell proliferation in piglets.

Authors:  C Lawrence Kien; Ruth Blauwiekel; Janice Y Bunn; Thomas L Jetton; Wendy L Frankel; Jens J Holst
Journal:  J Nutr       Date:  2007-04       Impact factor: 4.798

2.  Duodenojejunal Bypass Leads to Altered Gut Microbiota and Strengthened Epithelial Barriers in Rats.

Authors:  Po-Jen Yang; Wei-Shiung Yang; Hsiao-Ching Nien; Chiung-Nien Chen; Po-Huang Lee; Linda Chia-Hui Yu; Ming-Tsan Lin
Journal:  Obes Surg       Date:  2016-07       Impact factor: 4.129

Review 3.  Potential Hormone Mechanisms of Bariatric Surgery.

Authors:  Georgios K Dimitriadis; Manpal S Randeva; Alexander D Miras
Journal:  Curr Obes Rep       Date:  2017-09

4.  Neuroprotective Effects of a Cholecystokinin Analogue in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Parkinson's Disease Mouse Model.

Authors:  Zijuan Zhang; Hai Li; Yunfang Su; Jinlian Ma; Ye Yuan; Ziyang Yu; Ming Shi; Simai Shao; Zhenqiang Zhang; Christian Hölscher
Journal:  Front Neurosci       Date:  2022-03-15       Impact factor: 4.677

5.  The effect of bariatric surgery on intestinal absorption and transit time.

Authors:  Kirstin A Carswell; Royce P Vincent; Ajay P Belgaumkar; Roy A Sherwood; Stephanie A Amiel; Ameet G Patel; Carel W le Roux
Journal:  Obes Surg       Date:  2014-05       Impact factor: 4.129

Review 6.  Neurohormonal Changes in the Gut-Brain Axis and Underlying Neuroendocrine Mechanisms following Bariatric Surgery.

Authors:  Eirini Martinou; Irena Stefanova; Evangelia Iosif; Angeliki M Angelidi
Journal:  Int J Mol Sci       Date:  2022-03-19       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.